| Transcranial electrical and magnetic stimulation (tES and TMS) for addiction medicine: a consensus paper on the present state of the science and the road ahead H Ekhtiari, H Tavakoli, G Addolorato, C Baeken, A Bonci, S Campanella, ... Neuroscience & Biobehavioral Reviews 104, 118-140, 2019 | 261 | 2019 |
| Early synaptic dysfunction in Parkinson's disease: insights from animal models T Schirinzi, G Madeo, G Martella, M Maltese, B Picconi, P Calabresi, ... Movement Disorders 31 (6), 802-813, 2016 | 160 | 2016 |
| Centrality of striatal cholinergic transmission in basal ganglia function P Bonsi, D Cuomo, G Martella, G Madeo, T Schirinzi, F Puglisi, G Ponterio, ... Frontiers in Neuroanatomy 5, 2011 | 140 | 2011 |
| Guidelines for TMS/tES clinical services and research through the COVID-19 pandemic M Bikson, CA Hanlon, AJ Woods, BT Gillick, L Charvet, C Lamm, ... Brain stimulation 13 (4), 1124-1149, 2020 | 114 | 2020 |
| Cholinergic dysfunction alters synaptic integration between thalamostriatal and corticostriatal inputs in DYT1 dystonia G Sciamanna, A Tassone, G Mandolesi, F Puglisi, G Ponterio, G Martella, ... Journal of Neuroscience 32 (35), 11991-12004, 2012 | 111 | 2012 |
| Anticholinergic drugs rescue synaptic plasticity in DYT1 dystonia: Role of M1 muscarinic receptors M Maltese, G Martella, G Madeo, I Fagiolo, A Tassone, G Ponterio, ... Movement disorders 29 (13), 1655-1665, 2014 | 97 | 2014 |
| Regional specificity of synaptic plasticity deficits in a knock-in mouse model of DYT1 dystonia G Martella, M Maltese, R Nistico, T Schirinzi, G Madeo, G Sciamanna, ... Neurobiology of disease 65, 124-132, 2014 | 94 | 2014 |
| Pisa syndrome in Parkinson disease: an observational multicenter Italian study M Tinazzi, A Fasano, C Geroin, F Morgante, R Ceravolo, S Rossi, ... Neurology 85 (20), 1769-1779, 2015 | 91 | 2015 |
| Developmental profile of the aberrant dopamine D2 receptor response in striatal cholinergic interneurons in DYT1 dystonia G Sciamanna, A Tassone, G Martella, G Mandolesi, F Puglisi, D Cuomo, ... PloS one 6 (9), e24261, 2011 | 89 | 2011 |
| Metabotropic glutamate receptor subtype 4 selectively modulates both glutamate and GABA transmission in the striatum: implications for Parkinson’s disease treatment D Cuomo, G Martella, E Barabino, P Platania, D Vita, G Madeo, C Selvam, ... Journal of neurochemistry 109 (4), 1096-1105, 2009 | 89 | 2009 |
| Basal ganglia and beyond: the interplay between motor and cognitive aspects in Parkinson’s disease rehabilitation D Ferrazzoli, P Ortelli, G Madeo, N Giladi, GM Petzinger, G Frazzitta Neuroscience & Biobehavioral Reviews 90, 294-308, 2018 | 81 | 2018 |
| Homeostatic changes of the endocannabinoid system in Parkinson's disease V Pisani, G Madeo, A Tassone, G Sciamanna, M Maccarrone, ... Movement disorders 26 (2), 216-222, 2011 | 63 | 2011 |
| PINK1 heterozygous mutations induce subtle alterations in dopamine‐dependent synaptic plasticity G Madeo, T Schirinzi, G Martella, EC Latagliata, F Puglisi, J Shen, ... Movement Disorders 29 (1), 41-53, 2014 | 56 | 2014 |
| Exposure to low-dose rotenone precipitates synaptic plasticity alterations in PINK1 heterozygous knockout mice G Martella, G Madeo, M Maltese, V Vanni, F Puglisi, E Ferraro, T Schirinzi, ... Neurobiology of Disease 91, 21-36, 2016 | 52 | 2016 |
| Efficacy and safety profile of prolonged release oxycodone in combination with naloxone (OXN PR) in Parkinson’s disease patients with chronic pain G Madeo, T Schirinzi, S Natoli, M Pierantozzi, A Stefani, M Dauri, A Pisani Journal of neurology 262, 2164-2170, 2015 | 50 | 2015 |
| A clinical and biochemical analysis in the differential diagnosis of idiopathic normal pressure hydrocephalus T Schirinzi, GM Sancesario, C Ialongo, P Imbriani, G Madeo, S Toniolo, ... Frontiers in neurology 6, 86, 2015 | 50 | 2015 |
| Activation of 5-HT6 receptors inhibits corticostriatal glutamatergic transmission A Tassone, G Madeo, T Schirinzi, D Vita, F Puglisi, G Ponterio, F Borsini, ... Neuropharmacology 61 (4), 632-637, 2011 | 48 | 2011 |
| Genetic deletion of vesicular glutamate transporter in dopamine neurons increases vulnerability to MPTP-induced neurotoxicity in mice H Shen, RAM Marino, RA McDevitt, GH Bi, K Chen, G Madeo, PT Lee, ... Proceedings of the National Academy of Sciences 115 (49), E11532-E11541, 2018 | 41 | 2018 |
| Negative allosteric modulation of mGlu5 receptor rescues striatal D2 dopamine receptor dysfunction in rodent models of DYT1 dystonia G Sciamanna, G Ponterio, A Tassone, M Maltese, G Madeo, G Martella, ... Neuropharmacology 85, 440-450, 2014 | 40 | 2014 |
| Distinct roles of group I mGlu receptors in striatal function P Bonsi, P Platania, G Martella, G Madeo, D Vita, A Tassone, G Bernardi, ... Neuropharmacology 55 (4), 392-395, 2008 | 34 | 2008 |
